Synergistic interactions between cefalexin and kanamycin in Mueller-Hinton broth medium and in milk
- PMID: 19302331
- DOI: 10.1111/j.1365-2672.2009.04191.x
Synergistic interactions between cefalexin and kanamycin in Mueller-Hinton broth medium and in milk
Abstract
Aims: This study investigated the in vitro bactericidal activity of an intramammary drug product by comparing the kill kinetics of cefalexin and kanamycin, alone and in fixed ratio combination, against Streptococcus uberis, Staphylococcus aureus and Escherichia coli strains isolated from field cases of bovine mastitis. The effect of milk as a diluent on the rate of bacterial killing was also assessed.
Methods and results: Antibacterial kill kinetics was determined against each bacterial strain in Mueller-Hinton broth (MHB) and in milk. In MHB, the fixed cefalexin : kanamycin combination (1.5 : 1 w/w) exhibited a clear synergistic bactericidal activity against the strains tested. The combination also showed an enhanced killing activity in milk, as compared to either agent alone.
Conclusions: The data show the occurrence of synergistic interactions between cefalexin and kanamycin, resulting in a faster and enhanced bactericidal activity against major mastitis pathogens.
Significance and impact of the study: The study demonstrated that the combination exhibited a larger and faster rate of kill of S. aureus, S. uberis and E. coli compared to either cefalexin or kanamycin alone, while using a lower total amount of antibiotic. Synergistic and additive effects were also observed when milk was used as a medium. The results support the use of this combination of narrow spectrum antibiotics to treat clinical mastitis via the intramammary route and provide data on its killing kinetics.
Comment in
-
In vitro studies as supporting evidence on the efficacy of antimicrobials for mastitis treatment.J Appl Microbiol. 2009 Dec 1;107(6):2116-7. doi: 10.1111/j.1365-2672.2009.04538.x. Epub 2009 Oct 7. J Appl Microbiol. 2009. PMID: 19811570 No abstract available.
Similar articles
-
Evaluating the in vitro susceptibility of bovine mastitis pathogens to a combination of kanamycin and cefalexin: Recommendations for a disk diffusion test.J Dairy Sci. 2009 Dec;92(12):6217-27. doi: 10.3168/jds.2009-2282. J Dairy Sci. 2009. PMID: 19923627
-
Kill rate of mastitis pathogens by a combination of cefalexin and kanamycin.J Appl Microbiol. 2011 Jan;110(1):184-90. doi: 10.1111/j.1365-2672.2010.04876.x. Epub 2010 Oct 22. J Appl Microbiol. 2011. PMID: 20969677
-
Susceptibility of coagulase-negative staphylococci to a kanamycin and cefalexin combination.J Dairy Sci. 2012 Jun;95(6):3448-53. doi: 10.3168/jds.2011-5032. J Dairy Sci. 2012. PMID: 22612980
-
Antibacterial effect of plant-derived antimicrobials on major bacterial mastitis pathogens in vitro.J Dairy Sci. 2009 Apr;92(4):1423-9. doi: 10.3168/jds.2008-1384. J Dairy Sci. 2009. PMID: 19307623
-
Synergistic bactericidal effects and mechanisms of low intensity ultrasound and antibiotics against bacteria: a review.Ultrason Sonochem. 2012 May;19(3):377-82. doi: 10.1016/j.ultsonch.2011.11.010. Epub 2011 Nov 25. Ultrason Sonochem. 2012. PMID: 22153228 Review.
Cited by
-
Factors affecting cure when treating bovine clinical mastitis with cephalosporin-based intramammary preparations.J Dairy Sci. 2009 May;92(5):1941-53. doi: 10.3168/jds.2008-1497. J Dairy Sci. 2009. PMID: 19389951 Free PMC article.
-
Effects of Growth Medium and Inoculum Size on Pharmacodynamics Activity of Marbofloxacin against Staphylococcus aureus Isolated from Caprine Clinical Mastitis.Antibiotics (Basel). 2021 Oct 22;10(11):1290. doi: 10.3390/antibiotics10111290. Antibiotics (Basel). 2021. PMID: 34827228 Free PMC article.
-
Revealing microbial diversity in buffalo milk with high somatic cell counts: implications for mastitis diagnosis and treatment.Vet Res Commun. 2024 Aug;48(4):2537-2553. doi: 10.1007/s11259-024-10438-5. Epub 2024 Jun 14. Vet Res Commun. 2024. PMID: 38874832
-
Tomatidine and analog FC04-100 possess bactericidal activities against Listeria, Bacillus and Staphylococcus spp.BMC Pharmacol Toxicol. 2018 Feb 13;19(1):7. doi: 10.1186/s40360-018-0197-2. BMC Pharmacol Toxicol. 2018. PMID: 29439722 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials